Details of the Drug

General Information of Drug (ID: DM595I9)

Drug Name

Omilancor

Synonyms

BT-11; 1912399-75-7; A4Y49H6YY8; CHEMBL4788758; Piperazine-1,4-diylbis((6-(1H-benzo[d]imidazol-2-yl)pyridin-2-yl)methanone); Methanone, 1,1'-(1,4-piperazinediyl)bis(1-(6-(1H-benzimidazol-2-yl)-2-pyridinyl)-; [4-[6-(1H-benzimidazol-2-yl)pyridine-2-carbonyl]piperazin-1-yl]-[6-(1H-benzimidazol-2-yl)pyridin-2-yl]methanone; OMILANCOR; BT-11; Omilancor; OMILANCOR [INN]; UNII-A4Y49H6YY8; BT11; SCHEMBL17706588; GTPL10363; BCP32788; BT 11; BT11; Example 1 [US9556146B2]; BDBM50558735; s6419; AKOS037515592; CS-7521; SB18706; HY-102013

Indication

Disease Entry	ICD 11	Status	REF
Ulcerative colitis	DD71	Phase 2	[1]

Drug Type

Small molecule

Structure

3D MOL

2D MOL

Chemical Identifiers

Formula: C30H24N8O2
Canonical SMILES: C1CN(CCN1C(=O)C2=CC=CC(=N2)C3=NC4=CC=CC=C4N3)C(=O)C5=CC=CC(=N5)C6=NC7=CC=CC=C7N6
InChI: InChI=1S/C30H24N8O2/c39-29(25-13-5-11-23(31-25)27-33-19-7-1-2-8-20(19)34-27)37-15-17-38(18-16-37)30(40)26-14-6-12-24(32-26)28-35-21-9-3-4-10-22(21)36-28/h1-14H,15-18H2,(H,33,34)(H,35,36)
InChIKey: MVHWZNBAQIGPOQ-UHFFFAOYSA-N

Cross-matching ID

PubChem CID: 121299620
ChEBI ID: CHEMBL4788758
TTD ID: DC7JQ8

Drug-Molecule Activity Atlas (DMA)^NEW

Click to Jump to the Detailed DMA Information of This Drug

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
LanC-like protein 2 (LANCL2)	TTMK3EX	LANC2_HUMAN	Agonist	[2]

Molecular Interaction Atlas (MIA)

MIA Detail

Jump to Detail Molecular Interaction Atlas of This Drug

References

1	ClinicalTrials.gov (NCT05057273) A Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Oral BT-11 in Crohn's Disease Patients With Moderate to Severe Disease. U.S.National Institutes of Health.
2	Correction to: Efficacy, Safety, and Tolerability of ?Omilancor in a Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of Patients With Ulcerative Colitis. Inflamm Bowel Dis. 2022 Dec 1;28(12):1938.